Zheng Ye1, Yi Wei1, Jie Chen1, and Bin Song1
1West China Hospital, Sichuan University, Chengdu, China
Synopsis
Hepatocellular
carcinoma (HCC)
with highly aggressive characteristics is
usually actively proliferated and easily relapse, thereby requiring adjuvant therapies before surgery, like
preoperative TACE, to improve the patients’ prognosis. Ki-67 labeling index (LI)
was reported to be highly correlated with aggressive propensity of HCC, and
thus could affect the treatment response of the tumor and prognosis directly. Although most of HCC presented hypointensity on hepatobiliary
phase (HBP), the absolute signal intensity and relative contrast enhancement
ratio are not the same. In this study, we prospectively investigate the
usefulness of HBP quantitative parameters for preoperative prediction of aggressiveness in HCC patients.
Purpose
To prospectively determine whether the quantitative imaging parameters
derived from hepatobiliary phase (HBP) can be used for the preoperative
prediction of hepatocellular carcinoma (HCC) with highly aggressive
characteristics.Materials and Methods
One hundred and three patients with surgical-proven HCC were included
from July 2015 to June 2018. All MRI examinations were performed on a 3.0T MR
scanner (MAGNETOM Skyra, Siemens Healthcare, Erlangen, Germany) with an
18-channel phased torso coil. T1-weighted volume interpolated breath hold
(VIBE) gradient recall echo sequence was used for the acquisition of pre-enhancement
images, dynamic contrast enhanced phases and 20 mins HBP. Signal intensity (SI)
was measured by two independent reviewers. For liver parenchyma, three circle
region of interest (ROIs) with 3cm2 area were respectively placed on the left lobe, right lobe anterior and
posterior segments, avoiding major vessels, tumor, and bile ducts. For HCC
lesion, three freehand ROIs were draw along the tumor margin at or next the
level of the largest diameter of the tumor, excluding vessels and necrotic
areas (Figure 1). The average SI of liver parenchyma and tumor was
recorded as L0 and T0 based on PRE; and as
L20 and T20 based on HBP,
accordingly. Quantitative parameters including relative tumor enhancement [RTE,
(T20-T0)/T0], tumor to liver contrast ratio
(TLR, T20/L20), tumor enhancement
index [TEI,
(T20/L20)/(T0/L0)] and relative
enhancement ratio [RER,
(T20-T0)/(L20-L0)] were calculated. The
aggressive characteristics of HCC was identified by using Ki-67 labeling index
(LI) and classified into low aggressive (Ki-67 LI ≤ 10%) and high aggressive
(Ki-67 LI > 10%) groups. Difference of quantitative parameters between two
groups were assessed and the correlation between quantitative parameters and
Ki-67 LI was explored. Receiver operating characteristic analyses was used to
evaluate the predictive performance of quantitative parameters. To evaluate the inter-observer and intra-observer agreement of
quantitative parameters, intraclass correlation coefficient (ICC) and the
Bland-Altman plots were illustrated.Results
There was no significant difference in age, sex ratio, tumor size and
laboratory results between low and high aggressive groups in HCC patients (p > 0.05). The values of RTE, TLR, TEI and RER were significantly lower in high
aggressive group than low aggressive group (p < 0.05) (Figure
2) and negative correlations were obtained between these quantitative
parameters and Ki-67 LI (r ranges from -0.41 to -0.22, p < 0.05). TLR
demonstrated the highest predictive performance with the area under curve (AUC)
of 0.83 (95% confidence interval: 0.75-0.90), sensitivity of 89.0% and
specificity of 63.3% (Figure 3), and subsequent with RER, TEI, and RTE
with AUC of 0.78, 0.74 and 0.68 (Figure 4). Good to excellent inter-observer
agreement (ICC ranges from 0.85-0.89) and intra-observer agreement (ICC ranges
from 0.83-0.92) were found in the quantitative parameters (Figure 5).Discussion
Ki-67 LI has been reported as an independent prognostic indicator of HCC
in previous studies1-2. In current study, we
found that HCCs in high aggressive group showed significantly lower RTE, TLR,
TEI and RER, which agreed with previous studies that HCC with lower relative
tumoral SI on HBP had more aggressive biological behavior, such as advanced
tumor grades and shorter progression-free survival (PFS) rate. Jin et al. found that poorly
differentiated HCC could be preoperatively identified by TEI, which was also
reported to be one of the independent predictive indicators of HCC with E-S
grade IV3. Additionally, RER was found to be negatively correlated
with HCC histological grades (r = -0.775, p < 0.001).
Moreover, HCC patients with lower preoperative TLR showed higher tumor grades
and shorter PFS rate after hepatic arterial infusion chemotherapy4.
The reason why aggressive HCC tend to demonstrate lower relative tumoral SI
probably is that normal hepatocytes gradually turns into uncontrolled and actively
proliferated malignant tumor cells with higher Ki-67 LI during multistep hepatocarcinogenesis,
while at the same time, the expression of OATP usually decreased, hence resulting
in less uptake of Gd-EOB-DTPA.Conclusion
TLR
showed the highest predictive ability in HCC with high aggressiveness. Thus, our
results demonstrated that quantitative parameters based on the SI measurement
of HBP could preoperatively and noninvasively predict the aggressive
characteristics of HCC.Acknowledgements
None.References
1.
Cao Y, Ke R, Wang S, Zhu X, Chen J, Huang C, Jiang Y, Lv L. DNA topoisomerase
IIα and Ki67 are prognostic factors in patients with hepatocellular carcinoma.
Oncology letters 2017;13:4109-16.
2.
Li H-H, Qi L-N, Ma L, Chen Z-S, Xiang B-D, Li L-Q. Effect of KI-67 positive
cellular index on prognosis after hepatectomy in Barcelona Clinic Liver Cancer
stage A and B hepatocellular carcinoma with microvascular invasion. OncoTargets
and therapy 2018;11:4747-54
3.
Jin YJ, Cho SG, Lee KY, Kim JM, Lee JW. Association between relative liver
enhancement on gadoxetic acid enhanced magnetic resonance images and histologic
grade of hepatocellular carcinoma. Medicine (Baltimore) 2017;96:e7580.
4. Fujita N, Nishie A, Asayama Y, Ishigami K, Ushijima Y, Takayama Y, Okamoto
D, Morita K, Shirabe K, Koto K, Kubo Y, Oda Y, Honda H. Significance of the
Signal Intensity of Gadoxetic Acid-enhanced MR Imaging for Predicting the
Efficacy of Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma.
Magn Reson Med Sci 2016;15:111-20.